Crossref
In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate
ACTA Pharmaceutica Sciencia · 2026 · 64 (3) · 481
DOI: 10.23893/1307-2080.aps64025 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2026. Verfasst von Febri Odel Nitbani und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nitbani, F. O., Lulan, T. Y. K., Hahuly, M. V., Balle, J. S., Rozari, P. D., & Tjitda, P. J. P. (2026). In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate. ACTA Pharmaceutica Sciencia, 64(3), 481. https://doi.org/10.23893/1307-2080.aps64025
Vancouver
Nitbani FO, Lulan TYK, Hahuly MV, Balle JS, Rozari PD, Tjitda PJP. In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate. ACTA Pharmaceutica Sciencia. 2026;64(3):481. doi:10.23893/1307-2080.aps64025
BibTeX
@article{Nitbani2026,
author = {Nitbani, Febri Odel and Lulan, Theodore Yehezkiel Kristoferson and Hahuly, Mayavira Veronica and Balle, Jefri Semuel and Rozari, Philiphi De and Tjitda, Putra Jiwamurwa Pama},
title = {In silico design of ester lipophilic pyrazoline against dna gyrase as an antibacterial candidate},
journal = {ACTA Pharmaceutica Sciencia},
year = {2026},
volume = {64},
number = {3},
pages = {481},
doi = {10.23893/1307-2080.aps64025}
}
EUVIMED